The in vitro pancreatic cancer cell line data suggests that IGF1R signaling is required to induce a phenotypic switch of cells that possess low CD44 expression to one that shows a high level of CD44 expression with CD44s being the predominant isoform. The gene discussed is CD44; the disease is pancreatic neoplasm.